Charles Schwab’s ADMA Biologics ADMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$45.6M Buy
2,502,026
+40,021
+2% +$729K 0.01% 1161
2025
Q1
$48.8M Buy
2,462,005
+21,711
+0.9% +$431K 0.01% 1086
2024
Q4
$41.9M Buy
2,440,294
+38,761
+2% +$665K 0.01% 1254
2024
Q3
$48M Buy
2,401,533
+249,412
+12% +$4.99M 0.01% 1150
2024
Q2
$24.1M Buy
2,152,121
+377,001
+21% +$4.21M ﹤0.01% 1554
2024
Q1
$11.7M Buy
1,775,120
+138,417
+8% +$914K ﹤0.01% 1907
2023
Q4
$7.4M Buy
1,636,703
+27,357
+2% +$124K ﹤0.01% 2147
2023
Q3
$5.76M Buy
1,609,346
+1,039,893
+183% +$3.72M ﹤0.01% 2191
2023
Q2
$2.1M Buy
569,453
+7,231
+1% +$26.7K ﹤0.01% 2534
2023
Q1
$1.86M Buy
562,222
+76,212
+16% +$252K ﹤0.01% 2543
2022
Q4
$1.89M Buy
486,010
+7,798
+2% +$30.3K ﹤0.01% 2588
2022
Q3
$1.16M Buy
478,212
+639
+0.1% +$1.55K ﹤0.01% 2740
2022
Q2
$946K Buy
477,573
+408,346
+590% +$809K ﹤0.01% 2819
2022
Q1
$127K Hold
69,227
﹤0.01% 3381
2021
Q4
$98K Buy
+69,227
New +$98K ﹤0.01% 3437
2021
Q3
Sell
-58,927
Closed -$95K 3499
2021
Q2
$95K Sell
58,927
-118,327
-67% -$191K ﹤0.01% 3294
2021
Q1
$312K Buy
177,254
+20,247
+13% +$35.6K ﹤0.01% 3228
2020
Q4
$307K Buy
157,007
+12,077
+8% +$23.6K ﹤0.01% 3153
2020
Q3
$347K Sell
144,930
-8,697
-6% -$20.8K ﹤0.01% 2983
2020
Q2
$451K Sell
153,627
-19,627
-11% -$57.6K ﹤0.01% 2875
2020
Q1
$499K Buy
173,254
+59,420
+52% +$171K ﹤0.01% 2714
2019
Q4
$456K Hold
113,834
﹤0.01% 2851
2019
Q3
$507K Buy
113,834
+48,654
+75% +$217K ﹤0.01% 2795
2019
Q2
$253K Buy
65,180
+21,480
+49% +$83.4K ﹤0.01% 3054
2019
Q1
$166K Hold
43,700
﹤0.01% 3046
2018
Q4
$105K Hold
43,700
﹤0.01% 3085
2018
Q3
$272K Buy
43,700
+8,300
+23% +$51.7K ﹤0.01% 3023
2018
Q2
$160K Buy
+35,400
New +$160K ﹤0.01% 3083